XML 21 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue $ 3,862 $ 3,926
Operating expenses:    
Cost of goods sold (exclusive of depreciation and amortization) 12,743 11,806
Research and development 19,503 17,059
Selling, general and administrative 30,324 36,926
Depreciation and amortization 4,821 3,671
Total operating expenses 67,391 69,462
Operating loss (63,529) (65,536)
Other income (expense):    
Interest income (expense) (3,664) 901
Change in fair value of warrants (4,101) 24,675
Other loss, net (220) (184)
Loss before income taxes (71,514) (40,144)
Benefit (Provision) for income taxes (221) 28
Net loss (71,735) (40,116)
Foreign currency translation adjustment 827 1,492
Comprehensive loss (70,908) (38,624)
Net Income (Loss) (71,735) (40,116)
Net loss attributable to common stockholders $ (71,735) $ (40,116)
Weighted average of shares outstanding – basic (in shares) 107,972 101,029
Weighted average of shares outstanding – diluted (in shares) 107,972 101,029
Net loss attributable to common stockholder per share – basic (in Dollars per share) $ (0.66) $ (0.4)
Net loss attributable to common stockholder per share – diluted (in Dollars per share) $ (0.66) $ (0.4)